These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17612931)

  • 41. ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.
    Decker RH; Langer CJ; Rosenzweig KE; Chang JY; Gewanter RM; Ginsburg ME; Kong FM; Lally BE; Videtic GM; Movsas B
    Am J Clin Oncol; 2011 Oct; 34(5):537-44. PubMed ID: 21946673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvant chemotherapy for resected non-small-cell lung cancer.
    Solomon B; Mitchell JD; Bunn PA
    Oncology (Williston Park); 2005 Nov; 19(13):1685-97; discussion 1698-700, 1705. PubMed ID: 16425522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pre- and peri-surgical chemotherapy of stage I and II resectable non-small cell lung cancers].
    Depierre A
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S31-6. PubMed ID: 15536350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.
    Zhang Z; Xu F; Wang S; Li N; Wang C
    Lung Cancer; 2008 Jun; 60(3):434-40. PubMed ID: 18036699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
    Tanaka F; Wada H
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of preoperative chemotherapy for non-small-cell lung cancer: a meta-analysis.
    Nakamura H; Kawasaki N; Taguchi M; Kabasawa K
    Lung Cancer; 2006 Dec; 54(3):325-9. PubMed ID: 16987564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The emergence of a unique population in non-small cell lung cancer: systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy.
    Socinski MA; Stinchcombe TE; Hayes DN; Morris DE
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S32-8. PubMed ID: 16472707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meta-analyses of clinical trials in patients with non-small cell lung cancer. Minireview.
    Kovac V; Smrdel U
    Neoplasma; 2004; 51(5):334-40. PubMed ID: 15640936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapy.
    d'Amato TA; Pettiford BL; Schuchert MJ; Parker R; Ricketts WA; Luketich JD; Landreneau RJ
    Ann Surg Oncol; 2009 Oct; 16(10):2848-55. PubMed ID: 19609620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multimodality approach to early-stage non-small cell lung cancer.
    Scagliotti G
    Lung Cancer; 2007 Aug; 57 Suppl 2():S6-11. PubMed ID: 17686446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant therapy of resected non-small-cell lung cancer.
    Socinski MA
    Clin Lung Cancer; 2004 Nov; 6(3):162-9. PubMed ID: 15555217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant treatment of resected lung cancer.
    Chhatwani L; Cabebe E; Wakelee HA
    Proc Am Thorac Soc; 2009 Apr; 6(2):194-200. PubMed ID: 19349488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Adjuvant chemotherapy for non small cell lung cancer].
    Jankilevich G
    Medicina (B Aires); 2009; 69(1 Pt 2):177-81. PubMed ID: 19414303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Postoperative chemotherapy in non-small cell lung cancer].
    Milleron B; Gounant V; Giroux-Leprieur E; Lavolé A
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S64-8. PubMed ID: 18235396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adjuvant chemotherapy in the treatment of non-small cell lung cancer].
    Spásová I
    Cas Lek Cesk; 2007; 146(4):329-36. PubMed ID: 17491242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Early stages of non small cell lung cancer (I. II. IIIA). What is the best therapeutic strategy?].
    Riquet M; Berna P
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S36-16S42. PubMed ID: 17268334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjuvant chemotherapy for resected non-small cell lung cancer.
    Wakelee H; Chhatwani L
    Semin Thorac Cardiovasc Surg; 2008; 20(3):198-203. PubMed ID: 19038728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
    Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
    J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.
    Brahmer JR; Ettinger DS
    Respirology; 2007 May; 12(3):320-5. PubMed ID: 17539833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
    Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; Calabrò F; Campaldini B; Colaluca P; Molino A; Cetto GL
    Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.